                         SEQUENCE LISTING

<110>  Susavion Biosciences, Inc.
 
<120>  PRO-ANGIOGENIC PEPTIDES

<130>  EGGI-12034

<140>  Unassigned
<141>  2007-12-12

<150>  60/869,862
<151>  2006-12-13

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  1

Trp Asn Ser Thr Leu 
1               5   


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  2

Asn Gln His Thr Pro Arg 
1               5       


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker sequence

<400>  3

Gly Gly Gly Ser 
1               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  linker sequence

<400>  4

Gly Gly Gly Ser Gly Gly Gly Ser 
1               5               


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  5

Trp Asn Ser Thr Tyr 
1               5   


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  6

Tyr Asn Ser Thr Leu 
1               5   


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  7

Tyr Gln Pro Ser Leu 
1               5   


<210>  8
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  8

Val Gln Ala Thr Gln Ser 
1               5       


